HeartSciences Inc Warrant
HSCSW
5 hedge funds and large institutions have $32.4K invested in HeartSciences Inc Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
1.57% less ownership
Funds ownership: 7.65% → 6.08% (-1.6%)
68% less capital invested
Capital invested by funds: $100K → $32.4K (-$67.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$5.44K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.58K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$145 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CD
Chapin Davis
Baltimore,
Maryland
|
-$8.63K |
HSCSW Hedge Fund Activity: Q3 2023 in Review
5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q3 2023, worth a combined $32.4K — down 68% from $100K a quarter earlier.
Fund positioning in HSCSW was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Clear Street, adding an estimated $5.44K. The largest seller was Chapin Davis, exiting entirely with an estimated $8.63K sold.
- 5 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $32.4K of HeartSciences Inc Warrant stock for Q3 2023, down 68% quarter-over-quarter.
- 1 fund opened new HeartSciences Inc Warrant positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest HeartSciences Inc Warrant buyer in Q3 2023 was Clear Street, an estimated $5.44K added.
- The largest HeartSciences Inc Warrant seller in Q3 2023 was Chapin Davis, an estimated $8.63K sold.
Based on aggregated 13F filings for Q3 2023.